Culprit in Regorafenib Combo Failure in Metastatic Colorectal Cancer?

A 13% absolute increase in the radiographic response rate occurred in regorafenib-treated patients. Survival increases were not statistically significant.

Source: CancerNetwork - June 26, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news